Biocross Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.98M
Latest Deal Amount
  • Investors
  • 4

Biocross General Information


Developer of diagnostic systems intended to treat neurodegenerative diseases. The company's systems use reliable blood-based diagnostic methods that can be applied in hospital settings, enabling patients to have access to a reduced cost of risk-assessment and diagnosis of neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Primary Office
  • Parque tecnológico de Boecillo
  • Avda. Francisco Valles, 8, Boecillo
  • 47151 Valladolid
  • Spain
+34 983 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocross Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC $1.98M 00.000 Completed Generating Revenue
4. Later Stage VC 07-Apr-2011 00000 00.000 Completed Generating Revenue
3. Early Stage VC 01-Apr-2010 00000 00000 Completed Startup
2. Seed Round 01-Jan-2008 $173K $173K Completed Startup
1. Grant $546K Completed Startup
To view Biocross’s complete valuation and funding history, request access »

Biocross Executive Team (3)

Name Title Board Seat Contact Info
Pablo Albendea President
Matt Mittino Manager Director
You’re viewing 2 of 3 executive team members. Get the full list »

Biocross Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocross Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ADE Financiación Capital Semilla Other Minority 000 0000 000000 0
CRB Inverbio Venture Capital Minority 000 0000 000000 0
Sodical Instituto Financiero de Castilla y León Venture Capital Minority 000 0000 000000 0
European Commission Government 000 0000 000000 0
To view Biocross’s complete investors history, request access »